Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	6.77T
Revenue (ttm)	2.08T
Net Income (ttm)	78.43B
Shares Out	82.34M
EPS (ttm)	952.50
PE Ratio	86.30
Forward PE	n/a
Dividend	1,000.00 (1.22%)
Ex-Dividend Date	Oct 30, 2024

Volume	60,454
Average Volume	27,306
Open	82,000
Previous Close	81,500
Day's Range	81,700 - 83,500
52-Week Range	58,400 - 110,900
Beta	0.38
RSI	51.67
Earnings Date	Aug 7, 2025

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.